金刚烷胺对药物性帕金森综合征的作用：血浆水平与疗效的关系。
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.
作者信息
Pacifici G M, Nardini M, Ferrari P, Latini R, Fieschi C, Morselli P L
出版信息
Br J Clin Pharmacol. 1976 Oct;3(5):883-9. doi: 10.1111/j.1365-2125.1976.tb00642.x.
Abstract
Amantadine, administered at a dose of 200 mg/day, antagonized the extapyramidal symptomatology induced by neuroleptic drugs in fifteen psychiatric patients. Steady-state levels were reached within 4-7 days of treatment. Individual plasma levels ranged from 200-900 ng/ml. Apparent plasma half-lives varied from 10-28.5 h with an apparent VD of 200-400 litres. A significant relationship was found between the plasma levels of amantadine and the effects on the extrapyramidal symptomatology. The data suggest a direct effect of amantadine on dopaminergic receptors.
摘要
金刚烷胺以每日200毫克的剂量给药，可对抗15名精神病患者中由抗精神病药物引起的锥体外系症状。治疗4至7天内达到稳态水平。个体血浆水平在200 - 900纳克/毫升之间。表观血浆半衰期在10 - 28.5小时之间，表观分布容积为200 - 400升。发现金刚烷胺的血浆水平与对锥体外系症状的影响之间存在显著关系。数据表明金刚烷胺对多巴胺能受体有直接作用。
相似文献
1
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.金刚烷胺对药物性帕金森综合征的作用：血浆水平与疗效的关系。
Br J Clin Pharmacol. 1976 Oct;3(5):883-9. doi: 10.1111/j.1365-2125.1976.tb00642.x.
2
Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.金刚烷胺与苯海索治疗抗精神病药所致帕金森综合征的对比研究
Am J Psychiatry. 1976 Aug;133(8):940-3. doi: 10.1176/ajp.133.8.940.
3
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].[使用米丹坦治疗和预防抗精神病药物综合征的经验]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1973;73(8):1218-23.
4
No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.比哌立登与金刚烷胺对帕金森氏症和迟发性运动障碍型不自主运动的疗效无差异：一项针对药物治疗的慢性精神分裂症患者的双盲交叉、安慰剂对照研究。
J Clin Psychiatry. 1995 Apr;56(4):167-70.
5
The effect of amantadine on neuroleptic-induced parkinsonism.金刚烷胺对抗精神病药物所致帕金森综合征的作用。
Act Nerv Super (Praha). 1973 May;15(2):93.
6
Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.甲磺酸苯扎托品与盐酸金刚烷胺治疗抗精神病药所致锥体外系症状的比较。
Compr Psychiatry. 1976 Nov-Dec;17(6):763-8. doi: 10.1016/0010-440x(76)90024-9.
7
The antiparkinson properties of amantadine in drug-induced parkinsonism.
J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):211-4.
8
[Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
Boll Chim Farm. 1972 Oct;111(10):610-5.
9
Development of tolerance to the therapeutic effect of amantadine on akathisia.对金刚烷胺治疗静坐不能疗效产生耐受性的发展过程。
J Clin Psychopharmacol. 1984 Aug;4(4):218-20.
10
Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
Nord Psykiatr Tidsskr. 1973;27(1):31-4. doi: 10.3109/08039487309096847.
引用本文的文献
1
Amantadine as a therapeutic option for neuropathic pain in dogs with degenerative lumbosacral stenosis.金刚烷胺作为患有退行性腰骶部狭窄的犬神经性疼痛的一种治疗选择。
BMC Vet Res. 2025 Jul 16;21(1):469. doi: 10.1186/s12917-025-04911-9.
2
Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.金刚烷胺：永恒钻石靶标的重新评估及新的治疗潜力。
J Neural Transm (Vienna). 2021 Feb;128(2):127-169. doi: 10.1007/s00702-021-02306-2. Epub 2021 Feb 23.
3
Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.金刚烷胺与精神分裂症的谷氨酸假说。抗精神病药恶性综合征的治疗经验。
J Neural Transm Gen Sect. 1993;92(1):57-65. doi: 10.1007/BF01245162.
4
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.盐酸金刚烷胺和盐酸金刚乙胺副作用的差异与药代动力学的差异有关。
Antimicrob Agents Chemother. 1983 Mar;23(3):458-64. doi: 10.1128/AAC.23.3.458.
5
Anti-parkinsonian drugs today.当今的抗帕金森病药物。
Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002.
6
Clinical pharmacokinetics of anti-parkinsonian drugs.抗帕金森病药物的临床药代动力学
Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.
7
Clinical pharmacokinetics of amantadine hydrochloride.盐酸金刚烷胺的临床药代动力学
Clin Pharmacokinet. 1988 Jan;14(1):35-51. doi: 10.2165/00003088-198814010-00003.
8
Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations.硫酸金刚烷胺治疗帕金森病：临床疗效、心理测量测试及血清浓度
J Neurol. 1989 Mar;236(3):153-6. doi: 10.1007/BF00314331.
9
Toxic effects of amantadine in patients with renal failure.金刚烷胺对肾衰竭患者的毒性作用。
Can Med Assoc J. 1979 Mar 17;120(6):695-8.
本文引用的文献
1
Amantadine in the treatment of Parkinson's disease.金刚烷胺治疗帕金森病
JAMA. 1969 May 19;208(7):1168-70.
2
[Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
Sist Nerv. 1970 Sep-Oct;22(5):273-85.
3
[Drug therapy of Parkinson's disease with amantadine and levodopa].
Sist Nerv. 1970 Mar-Jun;22(2):126-43.
4
Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.金刚烷胺治疗后大鼠纹状体中多巴胺的合成和释放增加。
Eur J Pharmacol. 1970;13(1):131-3. doi: 10.1016/0014-2999(70)90194-9.
5
The antiparkinson properties of amantadine in drug-induced parkinsonism.
J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):211-4.
6
Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.金刚烷胺在中枢和外周神经系统中的多巴胺和去甲肾上腺素释放作用：帕金森病可能的作用模式。
Eur J Pharmacol. 1971 Sep;16(1):27-38. doi: 10.1016/0014-2999(71)90053-7.
7
[Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
Minerva Med. 1971 Oct 31;62(82):4020-3.
8
The effect of amantadine on motor activity and catalepsy in rats.金刚烷胺对大鼠运动活性和僵住症的影响。
Psychopharmacologia. 1972;24(2):296-307. doi: 10.1007/BF00403648.
9
Amantadine for Parkinson's disease.
Neurology. 1971 Sep;21(9):958-62. doi: 10.1212/wnl.21.9.958.
10
Comparison of amantadine, placebo, and levodopa in Parkinson's disease.金刚烷胺、安慰剂和左旋多巴在帕金森病中的比较。
Neurology. 1974 Aug;24(8):715-20. doi: 10.1212/wnl.24.8.715.
Zotero 插件